Anthony Adamis

Anthony Adamis

Founder at
Eyebiotech Ltd.

Net worth: - $ as of 29/06/2026

67 year
Health Technology
Consumer Services
Commercial Services

Profile

Anthony P.
Adamis
is the founder of Eyebiotech Ltd., founded in 2021, where the title held is Director.
Current jobs include Independent Director at Spiral Therapeutics, Inc. since 2021; Director at Gyroscope Therapeutics Ltd. since 2021; Director at Kalaris TX, Inc. since 2021; Director at Retinal Degeneration Fund since 2021; Independent Director at Kalaris Therapeutics, Inc. since 2025; and Chief Scientific Officer at (OSI) Eyetech.
Former jobs include Director at Gyroscope Therapeutics Holdings Plc from 2021 to 2022; Independent Director at EyePoint, Inc. from 2022 to 2024; Chief Scientific Officer at Oldtech, Inc.; and Vice President & Global Head-Ophthalmology at Genentech, Inc. from 2009 to 2021.
Education includes undergraduate studies at the University of Illinois and a doctorate from Pritzker School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
-.--%
02/06/2026 0 ( -.--% ) - $ 29/06/2026

Anthony Adamis active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer -
Director/Board Member 30/09/2021
Director/Board Member 30/11/2021
Founder 08/07/2021
Director/Board Member 30/09/2021
Director/Board Member 31/10/2021

Former positions of Anthony Adamis

CompaniesPositionEnd
EYEPOINT, INC. Director/Board Member 02/09/2024
GYROSCOPE THERAPEUTICS HOLDINGS PLC Director/Board Member 16/02/2022
Corporate Officer/Principal 31/12/2020
░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ -
See the detail of Anthony Adamis's experience

Training of Anthony Adamis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

86

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Anthony Adamis